Bain Capital Life Sciences Investors, LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1244.3T
Holdings
26
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $247.7T | 19.91% | |
| 2 | NUVLNUVALENT INC | 2,697,267 | $202.5T | 16.28% | |
| 3 | DNTHDIANTHUS THERAPEUTICS INC | 2,992,028 | $89.8T | 7.21% | |
| 4 | IRONDISC MEDICINE INC | 1,317,213 | $82.0T | 6.59% | |
| 5 | KYTXKYVERNA THERAPEUTICS INC | 3,163,868 | $78.6T | 6.32% | |
| 6 | PHVSPHARVARIS N V | 3,303,381 | $76.3T | 6.14% | |
| 7 | YB4PSAVARA INC | 14,565,457 | $72.5T | 5.83% | |
| 8 | ANNXANNEXON INC | 8,703,268 | $62.4T | 5.02% | |
| 9 | SLDBSOLID BIOSCIENCES INC | 4,034,582 | $53.7T | 4.32% | |
| 10 | MDGLMADRIGAL PHARMACEUTICALS INC | 196,995 | $52.6T | 4.23% | |
| 11 | —MERSANA THERAPEUTICS INC | 8,663,673 | $38.8T | 3.12% | |
| 12 | CABACABALETTA BIO INC | 1,617,364 | $27.6T | 2.22% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $23.5T | 1.89% | |
| 14 | TNGXTANGO THERAPEUTICS INC | 2,892,663 | $23.0T | 1.85% | |
| 15 | ARQTARCUTIS BIOTHERAPEUTICS INC | 2,011,687 | $19.9T | 1.60% | |
| 16 | NRIXNURIX THERAPEUTICS INC | 1,132,397 | $16.6T | 1.34% | |
| 17 | SYRSSYROS PHARMACEUTICALS INC | 2,749,808 | $14.7T | 1.18% | |
| 18 | MRNS*MARINUS PHARMACEUTICALS INC | 1,393,380 | $12.6T | 1.01% | |
| 19 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $10.0T | 0.81% | |
| 20 | CCCCC4 THERAPEUTICS INC | 1,142,210 | $9.3T | 0.75% | |
| 21 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $8.2T | 0.66% | |
| 22 | IVVDINVIVYD INC | 1,799,595 | $8.0T | 0.64% | |
| 23 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.9T | 0.47% | |
| 24 | ACRSACLARIS THERAPEUTICS INC | 3,000,000 | $3.7T | 0.30% | |
| 25 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $3.0T | 0.24% | |
| 26 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.1T | 0.09% |